FENTANYL EPIDEMIC

She became a physician and, eventually, the chief internist in an emergency room at Tel Aviv's Rokach (Hadassah) Hospital.[8] After divorcing her first husband, she went to Rockefeller University in 1986 as an associate physician specializing in drug addiction. There, she was mentored by, and subsequently collaborated for two decades with, Mary Jeanne Kreek, who was known for the development of methadone therapy for heroin addiction.[8]

In 1993, Adelson founded a substance abuse center and research clinic. She and her husband opened the Dr. Miriam and Sheldon G. Adelson Research Clinic in Las Vegas seven years later.[10] She has published numerous scientific papers on the topic of drug addiction during her career and has been a guest investigator at Rockefeller University.[9]

Research:  dr. miriam adelson - Google Scholar 

Dr. Yngvild Olsen serves as the Director for the Center for Substance Abuse Treatment (CSAT). She has a long history of working within the addiction treatment field to expand access to care and enhance quality. She began her career as the Medical Director for the Johns Hopkins Hospital’s outpatient substance use treatment services while a full-time Assistant Professor in the Department of Medicine at the Johns Hopkins School of Medicine. She subsequently served as the Deputy Health Officer for Maryland’s Harford County Health Department, where she led a modernization of publicly funded substance use treatment services in collaboration with State and local partners. She next served as the Vice President of Clinical Affairs for the Baltimore Substance Abuse Systems, then the local addiction authority for Baltimore City. In that position, she played a central role in the expansion of buprenorphine treatment for opioid addiction in both specialty treatment and general ambulatory medical systems. Dr. Olsen has also served as Medical Consultant to the Maryland Behavioral Health Administration, as a clinical expert to the Maryland Addiction Consultation Service at the University of Maryland School of Medicine, and as an advisor on addiction interventions to the Baltimore City Health Department. From 2011 to 2021, she served as Medical Director for the Institutes for Behavior Resources/REACH Health Services, a comprehensive outpatient substance use disorder treatment program in Baltimore City.

Dr. Olsen has held numerous senior volunteer leadership positions in the field of addiction medicine. These have included vice president of the American Society of Addiction Medicine, president of the Maryland Association for the Treatment of Opioid Dependence, and president of the Maryland/DC Society of Addiction Medicine. She also has served on the boards of the National Council on Alcohol and Drug Dependence-Maryland, and Stop Stigma Now, and as a clinical expert to the Providers Clinical Support System (PCSS).

After graduating from Harvard Medical School, Dr. Olsen completed residency training in internal medicine and served as primary care chief resident at Boston Medical Center. She completed a Fellowship in General Internal Medicine at Johns Hopkins, during which time she received a Master in Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Dr. Olsen has written and lectured extensively on opioid use disorder and its treatments, the stigma of addiction, the integration of behavioral health and medical care, and clinical and policy solutions to the overdose epidemic. She draws inspiration from the opportunity to provide care for people with substance use disorders as an addiction medicine specialist and general internist.

 dr. yngvild K. Olsen - Google Scholar